CN Stock MarketDetailed Quotes

002349 Jinghua Pharmaceutical Group

Watchlist
  • 8.00
  • +0.62+8.40%
Market Closed Sep 30 15:00 CST
6.51BMarket Cap28.47P/E (TTM)

Jinghua Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
-9.43%720.31M
-11.82%367.13M
-3.90%1.51B
-4.71%1.12B
0.48%795.35M
1.87%416.36M
15.85%1.57B
21.26%1.18B
23.39%791.55M
22.19%408.73M
Operating revenue
-9.43%720.31M
-11.82%367.13M
-3.90%1.51B
-4.71%1.12B
0.48%795.35M
1.87%416.36M
15.85%1.57B
21.26%1.18B
23.39%791.55M
22.19%408.73M
Other operating revenue
40.25%11.26M
----
-31.75%15.41M
----
-10.72%8.03M
----
5.46%22.58M
----
23.59%8.99M
----
Total operating cost
-8.29%542.65M
-6.80%278.29M
-11.10%1.19B
-8.26%864.87M
-4.59%591.68M
-6.09%298.58M
13.53%1.33B
11.32%942.7M
19.47%620.12M
15.53%317.95M
Operating cost
-12.71%354.04M
-12.46%180.78M
-7.43%775.64M
-5.89%575.2M
-0.78%405.57M
0.34%206.5M
15.47%837.91M
18.62%611.2M
24.54%408.76M
16.47%205.81M
Operating tax surcharges
-3.89%10.42M
-7.00%5.3M
-4.83%21.3M
-3.53%15.81M
0.70%10.85M
0.21%5.7M
8.04%22.39M
7.51%16.39M
2.72%10.77M
8.39%5.68M
Operating expense
7.84%116.17M
22.61%57.96M
-9.58%227.97M
-6.55%164.99M
3.89%107.72M
-19.63%47.27M
17.25%252.12M
8.35%176.55M
19.00%103.69M
28.90%58.81M
Administration expense
5.86%55.93M
4.14%27.32M
-20.21%118.8M
-20.20%83.86M
-22.10%52.83M
-20.37%26.23M
8.20%148.9M
4.35%105.09M
7.33%67.82M
1.45%32.94M
Financial expense
-87.75%-26.41M
-2,923.92%-10.18M
-53.84%-23.15M
-38.64%-19.54M
-195.05%-14.07M
-359.80%-336.55K
-2,842.24%-15.05M
-1,899.88%-14.09M
-792.27%-4.77M
-112.29%-73.19K
-Interest expense (Financial expense)
11.74%1.46M
-11.80%725.9K
-62.12%2.57M
-65.67%1.93M
-67.84%1.31M
-68.88%823.03K
-47.50%6.79M
-37.47%5.62M
-29.72%4.06M
-22.62%2.64M
-Interest Income (Financial expense)
-117.09%-26.63M
-212.03%-10.04M
-55.09%-23.64M
-62.63%-18.42M
-99.43%-12.26M
-2.96%-3.22M
-7.60%-15.24M
-10.91%-11.32M
-7.03%-6.15M
-55.03%-3.13M
Research and development
12.95%32.51M
29.47%17.11M
-25.71%64.62M
-6.33%44.54M
-14.96%28.78M
-10.61%13.22M
16.35%86.98M
-10.85%47.56M
15.37%33.84M
1.52%14.78M
Credit Impairment Loss
12.48%-2.57M
81.37%-423.21K
61.23%-2.03M
67.85%-1.46M
39.07%-2.93M
26.85%-2.27M
59.29%-5.23M
64.88%-4.53M
-2,643.63%-4.81M
-164.42%-3.11M
Asset Impairment Loss
38.44%-1.26M
120.35%297.88K
65.72%-7.95M
85.43%-3.41M
67.85%-2.04M
71.09%-1.46M
18.85%-23.19M
-1,917.26%-23.41M
-364.56%-6.35M
-137.64%-5.06M
Other net revenue
692.60%7.32M
455.31%7.06M
-63.17%4.3M
136.64%2.26M
-117.69%-1.24M
-18.44%-1.99M
487.08%11.67M
-125.35%-6.17M
-13.94%6.99M
-111.30%-1.68M
Fair value change income
21.15%3.41M
216.42%2.87M
36.89%6.83M
26.50%5.11M
-8.36%2.81M
-44.22%905.98K
-84.45%4.99M
-86.95%4.04M
645.15%3.07M
265.61%1.62M
Invest income
363.31%1.6M
159.51%135.62K
-99.03%238.45K
-112.10%-292.45K
-147.23%-606.28K
-134.04%-227.9K
3,771.78%24.46M
-32.05%2.42M
-51.28%1.28M
-42.72%669.56K
-Including: Investment income associates
93.94%-29.08K
186.76%97.06K
---1.26M
---614.89K
---479.8K
---111.87K
----
----
----
----
Asset deal income
105.35%3.15K
----
-46.89%-87.05K
-26.46%-74.94K
-17,139.42%-58.91K
14,761.01%50.1K
89.77%-59.26K
-7,172.68%-59.26K
-140.78%-341.73
56.80%-341.73
Other revenue
286.76%6.14M
309.45%4.18M
-31.81%7.29M
-84.48%2.39M
-88.49%1.59M
-75.69%1.02M
41.56%10.7M
293.53%15.38M
298.87%13.79M
76.68%4.2M
Operating profit
-8.62%184.98M
-17.18%95.9M
31.56%330.85M
13.66%257.05M
13.46%202.43M
29.96%115.79M
39.32%251.48M
54.35%226.16M
36.67%178.41M
20.19%89.1M
Add:Non operating Income
-78.55%173.94K
-95.17%20.39K
-40.38%1.09M
341.48%807.32K
4,411.04%811.1K
54,461.01%422.03K
604.08%1.82M
-40.44%182.87K
-92.30%17.98K
-97.96%773.5
Less:Non operating expense
5,233.55%2.63M
18.02%51.11K
-27.42%2.25M
75.82%857.51K
-61.97%49.24K
13,301.49%43.31K
64.89%3.09M
159.07%487.73K
-28.35%129.49K
-99.08%323.16
Total profit
-10.17%182.53M
-17.48%95.87M
31.77%329.7M
13.79%257M
13.96%203.2M
30.39%116.17M
39.87%250.21M
54.02%225.86M
36.53%178.3M
20.18%89.1M
Less:Income tax cost
-6.77%27.62M
-18.95%13.88M
40.36%53.23M
1.07%36.87M
9.70%29.63M
20.25%17.13M
-2.58%37.92M
45.60%36.48M
43.48%27.01M
23.07%14.25M
Net profit
-10.75%154.91M
-17.22%81.98M
30.23%276.47M
16.24%220.13M
14.72%173.56M
32.31%99.04M
51.68%212.29M
55.75%189.38M
35.36%151.29M
19.65%74.85M
Net profit from continuing operation
-10.75%154.91M
-17.22%81.98M
30.23%276.47M
16.24%220.13M
14.72%173.56M
32.31%99.04M
51.68%212.29M
55.75%189.38M
35.36%151.29M
19.65%74.85M
Less:Minority Profit
2.71%19.47M
-4.11%10.9M
44,851.53%28.77M
20.88%24.78M
-10.62%18.96M
42.15%11.37M
100.31%64K
401.05%20.5M
253.89%21.21M
35.93%8M
Net profit of parent company owners
-12.40%135.43M
-18.92%71.08M
16.71%247.7M
15.68%195.35M
18.85%154.61M
31.14%87.67M
32.06%212.23M
31.52%168.88M
22.98%130.08M
17.96%66.86M
Earning per share
Basic earning per share
-12.43%0.1663
-18.94%0.0873
16.69%0.3042
15.67%0.2399
18.84%0.1899
31.18%0.1077
32.07%0.2607
31.52%0.2074
23.02%0.1598
17.96%0.0821
Diluted earning per share
-12.43%0.1663
-18.94%0.0873
16.69%0.3042
15.67%0.2399
18.84%0.1899
31.18%0.1077
32.07%0.2607
31.52%0.2074
23.02%0.1598
17.96%0.0821
Other composite income
-3.22M
Other composite income of parent company owners
----
----
---3.22M
----
----
----
----
----
----
----
Total composite income
-10.75%154.91M
-17.22%81.98M
28.71%273.24M
16.24%220.13M
14.72%173.56M
32.31%99.04M
51.68%212.29M
55.75%189.38M
35.36%151.29M
19.65%74.85M
Total composite income of parent company owners
-12.40%135.43M
-18.92%71.08M
15.20%244.47M
15.68%195.35M
18.85%154.61M
31.14%87.67M
32.06%212.23M
31.52%168.88M
22.98%130.08M
17.96%66.86M
Total composite income of minority owners
2.71%19.47M
-4.11%10.9M
44,851.53%28.77M
20.88%24.78M
-10.62%18.96M
42.15%11.37M
100.31%64K
401.05%20.5M
253.89%21.21M
35.93%8M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Tianheng Certified Public Accountants (Special General Partnership)
--
--
--
Tianheng Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue -9.43%720.31M-11.82%367.13M-3.90%1.51B-4.71%1.12B0.48%795.35M1.87%416.36M15.85%1.57B21.26%1.18B23.39%791.55M22.19%408.73M
Operating revenue -9.43%720.31M-11.82%367.13M-3.90%1.51B-4.71%1.12B0.48%795.35M1.87%416.36M15.85%1.57B21.26%1.18B23.39%791.55M22.19%408.73M
Other operating revenue 40.25%11.26M-----31.75%15.41M-----10.72%8.03M----5.46%22.58M----23.59%8.99M----
Total operating cost -8.29%542.65M-6.80%278.29M-11.10%1.19B-8.26%864.87M-4.59%591.68M-6.09%298.58M13.53%1.33B11.32%942.7M19.47%620.12M15.53%317.95M
Operating cost -12.71%354.04M-12.46%180.78M-7.43%775.64M-5.89%575.2M-0.78%405.57M0.34%206.5M15.47%837.91M18.62%611.2M24.54%408.76M16.47%205.81M
Operating tax surcharges -3.89%10.42M-7.00%5.3M-4.83%21.3M-3.53%15.81M0.70%10.85M0.21%5.7M8.04%22.39M7.51%16.39M2.72%10.77M8.39%5.68M
Operating expense 7.84%116.17M22.61%57.96M-9.58%227.97M-6.55%164.99M3.89%107.72M-19.63%47.27M17.25%252.12M8.35%176.55M19.00%103.69M28.90%58.81M
Administration expense 5.86%55.93M4.14%27.32M-20.21%118.8M-20.20%83.86M-22.10%52.83M-20.37%26.23M8.20%148.9M4.35%105.09M7.33%67.82M1.45%32.94M
Financial expense -87.75%-26.41M-2,923.92%-10.18M-53.84%-23.15M-38.64%-19.54M-195.05%-14.07M-359.80%-336.55K-2,842.24%-15.05M-1,899.88%-14.09M-792.27%-4.77M-112.29%-73.19K
-Interest expense (Financial expense) 11.74%1.46M-11.80%725.9K-62.12%2.57M-65.67%1.93M-67.84%1.31M-68.88%823.03K-47.50%6.79M-37.47%5.62M-29.72%4.06M-22.62%2.64M
-Interest Income (Financial expense) -117.09%-26.63M-212.03%-10.04M-55.09%-23.64M-62.63%-18.42M-99.43%-12.26M-2.96%-3.22M-7.60%-15.24M-10.91%-11.32M-7.03%-6.15M-55.03%-3.13M
Research and development 12.95%32.51M29.47%17.11M-25.71%64.62M-6.33%44.54M-14.96%28.78M-10.61%13.22M16.35%86.98M-10.85%47.56M15.37%33.84M1.52%14.78M
Credit Impairment Loss 12.48%-2.57M81.37%-423.21K61.23%-2.03M67.85%-1.46M39.07%-2.93M26.85%-2.27M59.29%-5.23M64.88%-4.53M-2,643.63%-4.81M-164.42%-3.11M
Asset Impairment Loss 38.44%-1.26M120.35%297.88K65.72%-7.95M85.43%-3.41M67.85%-2.04M71.09%-1.46M18.85%-23.19M-1,917.26%-23.41M-364.56%-6.35M-137.64%-5.06M
Other net revenue 692.60%7.32M455.31%7.06M-63.17%4.3M136.64%2.26M-117.69%-1.24M-18.44%-1.99M487.08%11.67M-125.35%-6.17M-13.94%6.99M-111.30%-1.68M
Fair value change income 21.15%3.41M216.42%2.87M36.89%6.83M26.50%5.11M-8.36%2.81M-44.22%905.98K-84.45%4.99M-86.95%4.04M645.15%3.07M265.61%1.62M
Invest income 363.31%1.6M159.51%135.62K-99.03%238.45K-112.10%-292.45K-147.23%-606.28K-134.04%-227.9K3,771.78%24.46M-32.05%2.42M-51.28%1.28M-42.72%669.56K
-Including: Investment income associates 93.94%-29.08K186.76%97.06K---1.26M---614.89K---479.8K---111.87K----------------
Asset deal income 105.35%3.15K-----46.89%-87.05K-26.46%-74.94K-17,139.42%-58.91K14,761.01%50.1K89.77%-59.26K-7,172.68%-59.26K-140.78%-341.7356.80%-341.73
Other revenue 286.76%6.14M309.45%4.18M-31.81%7.29M-84.48%2.39M-88.49%1.59M-75.69%1.02M41.56%10.7M293.53%15.38M298.87%13.79M76.68%4.2M
Operating profit -8.62%184.98M-17.18%95.9M31.56%330.85M13.66%257.05M13.46%202.43M29.96%115.79M39.32%251.48M54.35%226.16M36.67%178.41M20.19%89.1M
Add:Non operating Income -78.55%173.94K-95.17%20.39K-40.38%1.09M341.48%807.32K4,411.04%811.1K54,461.01%422.03K604.08%1.82M-40.44%182.87K-92.30%17.98K-97.96%773.5
Less:Non operating expense 5,233.55%2.63M18.02%51.11K-27.42%2.25M75.82%857.51K-61.97%49.24K13,301.49%43.31K64.89%3.09M159.07%487.73K-28.35%129.49K-99.08%323.16
Total profit -10.17%182.53M-17.48%95.87M31.77%329.7M13.79%257M13.96%203.2M30.39%116.17M39.87%250.21M54.02%225.86M36.53%178.3M20.18%89.1M
Less:Income tax cost -6.77%27.62M-18.95%13.88M40.36%53.23M1.07%36.87M9.70%29.63M20.25%17.13M-2.58%37.92M45.60%36.48M43.48%27.01M23.07%14.25M
Net profit -10.75%154.91M-17.22%81.98M30.23%276.47M16.24%220.13M14.72%173.56M32.31%99.04M51.68%212.29M55.75%189.38M35.36%151.29M19.65%74.85M
Net profit from continuing operation -10.75%154.91M-17.22%81.98M30.23%276.47M16.24%220.13M14.72%173.56M32.31%99.04M51.68%212.29M55.75%189.38M35.36%151.29M19.65%74.85M
Less:Minority Profit 2.71%19.47M-4.11%10.9M44,851.53%28.77M20.88%24.78M-10.62%18.96M42.15%11.37M100.31%64K401.05%20.5M253.89%21.21M35.93%8M
Net profit of parent company owners -12.40%135.43M-18.92%71.08M16.71%247.7M15.68%195.35M18.85%154.61M31.14%87.67M32.06%212.23M31.52%168.88M22.98%130.08M17.96%66.86M
Earning per share
Basic earning per share -12.43%0.1663-18.94%0.087316.69%0.304215.67%0.239918.84%0.189931.18%0.107732.07%0.260731.52%0.207423.02%0.159817.96%0.0821
Diluted earning per share -12.43%0.1663-18.94%0.087316.69%0.304215.67%0.239918.84%0.189931.18%0.107732.07%0.260731.52%0.207423.02%0.159817.96%0.0821
Other composite income -3.22M
Other composite income of parent company owners -----------3.22M----------------------------
Total composite income -10.75%154.91M-17.22%81.98M28.71%273.24M16.24%220.13M14.72%173.56M32.31%99.04M51.68%212.29M55.75%189.38M35.36%151.29M19.65%74.85M
Total composite income of parent company owners -12.40%135.43M-18.92%71.08M15.20%244.47M15.68%195.35M18.85%154.61M31.14%87.67M32.06%212.23M31.52%168.88M22.98%130.08M17.96%66.86M
Total composite income of minority owners 2.71%19.47M-4.11%10.9M44,851.53%28.77M20.88%24.78M-10.62%18.96M42.15%11.37M100.31%64K401.05%20.5M253.89%21.21M35.93%8M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Tianheng Certified Public Accountants (Special General Partnership)------Tianheng Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data